{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:54:13Z","timestamp":1762505653969},"reference-count":126,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.3109\/10673229.2010.507042","type":"journal-article","created":{"date-parts":[[2010,9,8]],"date-time":"2010-09-08T13:15:32Z","timestamp":1283951732000},"page":"266-278","source":"Crossref","is-referenced-by-count":19,"title":["The Pharmacological Treatment of Bipolar Disorder: The Question of Modern Advances"],"prefix":"10.1097","volume":"18","author":[{"given":"Jack","family":"Hirschowitz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Kolevzon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir","family":"Garakani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-2-20210129","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1176\/ajp.125.4.558","article-title":"Lithium comes into its own.","volume":"125","author":"Kline","year":"1968","journal-title":"Am J Psychiatry"},{"key":"R2-2-20210129","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1176\/ajp.125.8.1131","article-title":"Need for careful evaluation of lithium.","volume":"125","author":"Blackwell","year":"1969","journal-title":"Am J Psychiatry"},{"key":"R3-2-20210129","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1176\/ajp.125.8.1131-a","article-title":"Need for careful evaluation of lithium. Reply.","volume":"125","author":"Kline","year":"1969","journal-title":"Am J Psychiatry"},{"key":"R4-2-20210129","first-page":"19","article-title":"Rediscovering the art of lithium therapy.","volume":"1","author":"Jefferson","year":"2002","journal-title":"Curr Psychiatry"},{"key":"R5-2-20210129","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1001\/jama.1997.03550210043036","article-title":"Trends in antihypertensive drug use in the United States: do the JNC V recommendations affect prescribing Fifth Joint National Commission on the Detection, Evaluation, and Treatment of High Blood Pressure.","volume":"278","author":"Siegel","year":"1997","journal-title":"JAMA"},{"key":"R6-2-20210129","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/0895-4356(96)00019-4","article-title":"Rating the quality of evidence for clinical practice guidelines.","volume":"49","author":"Hadorn","year":"1996","journal-title":"J Clin Epidemiol"},{"key":"R8-2-20210129","doi-asserted-by":"crossref","first-page":"349","DOI":"10.5694\/j.1326-5377.1949.tb36912.x","article-title":"Lithium salts in the treatment of psychotic excitement.","volume":"36","author":"Cade","year":"1949","journal-title":"Med J Aust"},{"key":"R9-2-20210129","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1136\/jnnp.17.4.250","article-title":"The treatment of manic psychoses by the administration of lithium salts.","volume":"17","author":"Schou","year":"1954","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R10-2-20210129","first-page":"349","article-title":"Prophylactic lithium L","volume":"2","author":"Baastrup","year":"1968","journal-title":"ancet"},{"key":"R13-2-20210129","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1192\/bjp.171.2.113","article-title":"Lithium: evidence reconsidered.","volume":"171","author":"Moncrieff","year":"1997","journal-title":"Br J Psychiatry"},{"key":"R14-2-20210129","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0010-440X(68)80053-7","article-title":"Controlled evaluation of lithium and chlorpromazine in the treatment of manic states: an interim report.","volume":"9","author":"Johnson","year":"1968","journal-title":"Compr Psychiatry"},{"key":"R15-2-20210129","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1192\/bjp.109.458.56","article-title":"Treatment of manic illness with lithium carbonate.","volume":"109","author":"Maggs","year":"1963","journal-title":"Br J Psychiatry"},{"key":"R16-2-20210129","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1001\/archpsyc.1969.01740220102012","article-title":"Lithium-carbonate treatment in depression and mania. A longitudinal double-blind study.","volume":"21","author":"Goodwin","year":"1969","journal-title":"Arch Gen Psychiatry"},{"key":"R17-2-20210129","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0140-6736(70)92870-9","article-title":"Prophylactic lithium: double blind discontinuation in manic-depressive and recurrent-depressive disorders.","volume":"2","author":"Baastrup","year":"1970","journal-title":"Lancet"},{"key":"R18-2-20210129","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1192\/bjp.116.535.621","article-title":"Prophylactic lithium: a double-blind trial in recurrent affective disorders.","volume":"116","author":"Melia","year":"1970","journal-title":"Br J Psychiatry"},{"key":"R19-2-20210129","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1001\/archpsyc.1991.01810360046007","article-title":"Risk of recurrence following discontinuation of lithium treatment in bipolar disorder.","volume":"48","author":"Suppes","year":"1991","journal-title":"Arch Gen Psychiatry"},{"key":"R21-2-20210129","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1176\/ajp.127.3.351","article-title":"A comparison of lithium carbonate and chlorpromazine in mania.","volume":"127","author":"Platman","year":"1970","journal-title":"Am J Psychiatry"},{"key":"R22-2-20210129","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1176\/ajp.126.9.1306","article-title":"A double-blind comparison of lithium and chlorpromazine in the treatment of manic states.","volume":"126","author":"Spring","year":"1970","journal-title":"Am J Psychiatry"},{"key":"R23-2-20210129","first-page":"93","article-title":"Drug Ther B","volume":"2","year":"1964","journal-title":"ull"},{"key":"R24-2-20210129","first-page":"451","article-title":"Antimanic effect of clonazepam.","volume":"18","author":"Chouinard","year":"1983","journal-title":"Biol Psychiatry"},{"key":"R25-2-20210129","first-page":"173","article-title":"The use of carbamazepine (Tegretol) in the control of manic-depressive psychosis and other manic-depressive states.","volume":"13","author":"Takezaki","year":"1971","journal-title":"Seishin Igaku"},{"key":"R26-2-20210129","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1528-1157.1971.tb04380.x","article-title":"Antiepileptic and psychotropic effect of carbamazepine (Tegretol) in the treatment of psychomotor epilepsy.","volume":"12","author":"Dalby","year":"1971","journal-title":"Epilepsia"},{"key":"R27-2-20210129","first-page":"707","article-title":"Neuropsychotropic action of a new anti-epileptic agent: depamide.","volume":"124","author":"Lambert","year":"1966","journal-title":"Ann Med Psychol (Paris)"},{"key":"R28-2-20210129","first-page":"159","article-title":"Therapeutic effects of carbamazepine in affective illness: a preliminary report.","volume":"2","author":"Ballenger","year":"1978","journal-title":"Commun Psychopharmacol"},{"key":"R29-2-20210129","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1176\/ajp.137.7.782","article-title":"Carbamazepine in manic depressive illness: a new treatment.","volume":"137","author":"Ballenger","year":"1980","journal-title":"Am J Psychiatry"},{"key":"R31-2-20210129","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1176\/ajp.147.4.431","article-title":"Spectrum of efficacy of valproate in 55 patients with rapid-cycling bipolar disorder.","volume":"147","author":"Calabrese","year":"1990","journal-title":"Am J Psychiatry"},{"key":"R32-2-20210129","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1176\/appi.ajp.162.11.2152","article-title":"A 20-month, double-blind, maintenance trial of lithium versus divalproex in rapid-cycling bipolar disorder.","volume":"162","author":"Calabrese","year":"2005","journal-title":"Am J Psychiatry"},{"key":"R33-2-20210129","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1399-5618.2007.00500.x","article-title":"Lamotrigine in the acute treatment of bipolar depression: results of five double-blind, placebo-controlled clinical trials.","volume":"10","author":"Calabrese","year":"2008","journal-title":"Bipolar Disord"},{"key":"R34-2-20210129","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1176\/appi.ajp.162.7.1351","article-title":"A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression.","volume":"162","author":"Calabrese","year":"2005","journal-title":"Am J Psychiatry"},{"key":"R35-2-20210129","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/01.jcp.0000248603.76231.b7","article-title":"; BOLDER II Study Group. Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study).","volume":"26","author":"Thase","year":"2006","journal-title":"J Clin Psychopharmacol"},{"key":"R36-2-20210129","first-page":"29","article-title":"A randomized, double-blind, placebo-controlled study of quetiapine in the treatment of bipolar I and II depression: improvements in quality of life.","volume":"22","author":"Endicott","year":"2007","journal-title":"Int Clin Psychopharmacol"},{"key":"R37-2-20210129","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1176\/appi.ajp.161.9.1537","article-title":"Antidepressants for bipolar depression: a systematic review of randomized, controlled trials.","volume":"161","author":"Gijsman","year":"2004","journal-title":"Am J Psychiatry"},{"key":"R38-2-20210129","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMoa064135","article-title":"Effectiveness of adjunctive antidepressant treatment for bipolar depression.","volume":"356","author":"Sachs","year":"2007","journal-title":"N Engl J Med"},{"key":"R39-2-20210129","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000202824","article-title":"Antidepressant-induced mood conversions in bipolar disorder: a retrospective study of tricyclic versus non-tricyclic antidepressant drugs.","volume":"59","author":"Koszewska","year":"2009","journal-title":"Neuropsychobiology"},{"key":"R40-2-20210129","first-page":"790","article-title":"Switching, induction of rapid cycling, and increased suicidality with antidepressants in bipolar patients: fact or overinterpretation CNS S","volume":"13","author":"Grunze","year":"2008","journal-title":"pectr"},{"key":"R41-2-20210129","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1600-0447.2008.01237.x","article-title":"Are antidepressants safe in the treatment of bipolar depression A critical evaluation of their potential risk to induce switch into mania or cycle acceleration.","volume":"118","author":"Licht","year":"2008","journal-title":"Acta Psychiatr Scand"},{"key":"R43-2-20210129","first-page":"1","article-title":"Practice guideline for the treatment of patients with bipolar disorder (revision).","volume":"159","year":"2002","journal-title":"Am J Psychiatry"},{"key":"R44-2-20210129","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/0269881103017002003","article-title":"Consensus Group of the British Association for Psychopharmacology. Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology.","volume":"17","author":"Goodwin","year":"2003","journal-title":"J Psychopharmacol"},{"key":"R45-2-20210129","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1017\/S1461145708009231","article-title":"Treatment of bipolar disorder: a systematic review of available data and clinical perspectives.","volume":"11","author":"Fountoulakis","year":"2008","journal-title":"Int J Neuropsychopharmacol"},{"key":"R46-2-20210129","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1176\/appi.ajp.161.1.3","article-title":"What is a mood stabilizer An evidence-based response.","volume":"161","author":"Bauer","year":"2004","journal-title":"Am J Psychiatry"},{"key":"R47-2-20210129","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1080\/15622970410029924","article-title":"The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part III: maintenance treatment.","volume":"5","author":"Grunze","year":"2004","journal-title":"World J Biol Psychiatry"},{"key":"R48-2-20210129","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0140-6736(02)07450-0","article-title":"Bipolar disorder.","volume":"359","author":"Muller-Oerlinghausen","year":"2002","journal-title":"Lancet"},{"key":"R49-2-20210129","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1192\/bjp.119.550.267","article-title":"Comparative effects of lithium and chlorpromazine in the treatment of acute manic states.","volume":"119","author":"Johnson","year":"1971","journal-title":"Br J Psychiatry"},{"key":"R50-2-20210129","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1192\/bjp.120.557.409","article-title":"Relationship between serum lithium level and clinical response in acute mania treated with lithium.","volume":"120","author":"Prien","year":"1972","journal-title":"Br J Psychiatry"},{"key":"R51-2-20210129","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1001\/archpsyc.1975.01760280108010","article-title":"Comparison of efficacy of lithium carbonate and chlorpromazine in mania. Report of collaborative study group on treatment of mania in Japan.","volume":"32","author":"Takahashi","year":"1975","journal-title":"Arch Gen Psychiatry"},{"key":"R52-2-20210129","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1001\/archpsyc.1975.01760190036004","article-title":"Psychoactive drugs in mania. A controlled comparison of lithium carbonate, chlorpromazine, and haloperidol.","volume":"32","author":"Shopsin","year":"1975","journal-title":"Arch Gen Psychiatry"},{"key":"R53-2-20210129","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jama.1994.03510360044034","article-title":"Efficacy of divalproex vs. lithium and placebo in the treatment of mania. Depakote Mania Study Group.","volume":"271","author":"Bowden","year":"1994","journal-title":"JAMA"},{"key":"R54-2-20210129","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4088\/JCP.v66n0116","article-title":"A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder.","volume":"66","author":"Bowden","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"R55-2-20210129","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1176\/appi.ajp.161.2.217","article-title":"Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials.","volume":"161","author":"Geddes","year":"2004","journal-title":"Am J Psychiatry"},{"issue":"3","key":"R56-2-20210129","first-page":"CD003013","article-title":"Lithium for maintenance treatment of mood disorders.","author":"Burgess","year":"2001","journal-title":"Cochrane Database Syst Rev"},{"key":"R57-2-20210129","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1176\/ajp.133.4.373","article-title":"Lithium in the treatment of depression.","volume":"133","author":"Mendels","year":"1976","journal-title":"Am J Psychiatry"},{"key":"R58-2-20210129","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1176\/ajp.129.1.44","article-title":"Lithium response in unipolar versus bipolar depression.","volume":"129","author":"Goodwin","year":"1972","journal-title":"Am J Psychiatry"},{"key":"R59-2-20210129","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1001\/archpsyc.1975.01760270039003","article-title":"Lithium carbonate response in depression. Prediction by unipolarbipolar illness, average-evoked response, catechol-O-methyl transferase, and family history.","volume":"32","author":"Baron","year":"1975","journal-title":"Arch Gen Psychiatry"},{"key":"R60-2-20210129","doi-asserted-by":"crossref","first-page":"150","DOI":"10.4088\/JCP.08m04995gre","article-title":"A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I).","volume":"71","author":"Young","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"R61-2-20210129","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.2165\/11318850-000000000-00000","article-title":"The management of individuals with bipolar disorder: a review of the evidence and its integration into clinical practice.","volume":"69","author":"Malhi","year":"2009","journal-title":"Drugs"},{"key":"R62-2-20210129","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1177\/106002809603001206","article-title":"Neuroleptics in acute mania: a pharmacoepidemiologic study.","volume":"30","author":"Chou","year":"1996","journal-title":"Ann Pharmacother"},{"key":"R63-2-20210129","doi-asserted-by":"crossref","first-page":"509","DOI":"10.4088\/JCP.v67n0401","article-title":"Atypical antipsychotics in the treatment of mania: a meta-analysis of randomized, placebo-controlled trials.","volume":"67","author":"Perlis","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"R64-2-20210129","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1176\/ajp.156.5.702","article-title":"Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group.","volume":"156","author":"Tohen","year":"1999","journal-title":"Am J Psychiatry"},{"key":"R65-2-20210129","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1001\/archpsyc.57.9.841","article-title":"Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzapine HGGW Study Group.","volume":"57","author":"Tohen","year":"2000","journal-title":"Arch Gen Psychiatry"},{"key":"R66-2-20210129","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/00004850-199911000-00003","article-title":"Olanzapine compared to lithium in mania: a double-blind randomized controlled trial.","volume":"14","author":"Berk","year":"1999","journal-title":"Int Clin Psychopharmacol"},{"key":"R67-2-20210129","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.4088\/JCP.v63n1210","article-title":"A comparison of the efficacy, safety, and tolerability of divalproex sodium and olanzapine in the treatment of bipolar disorder.","volume":"63","author":"Zajecka","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"R68-2-20210129","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1176\/appi.ajp.160.7.1263","article-title":"Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study.","volume":"160","author":"Tohen","year":"2003","journal-title":"Am J Psychiatry"},{"key":"R69-2-20210129","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.4088\/JCP.v69n1113","article-title":"Olanzapine versus divalproex versus placebo in the treatment of mild to moderate mania: a randomized, 12-week, double-blind study.","volume":"69","author":"Tohen","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"R70-2-20210129","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1177\/0269881108098820","article-title":"A UK consensus on the administration of aripiprazole for the treatment of mania.","volume":"23","author":"Aitchison","year":"2009","journal-title":"J Psychopharmacol"},{"key":"R71-2-20210129","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1192\/bjp.bp.108.049965","article-title":"Aripiprazole monotherapy in acute mania: 12-week randomised placebo- and haloperidol-controlled study.","volume":"194","author":"Young","year":"2009","journal-title":"Br J Psychiatry"},{"key":"R72-2-20210129","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jad.2008.05.014","article-title":"; CN138-135 Study Group. Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double-blind, placebo- and lithium-controlled study.","volume":"112","author":"Keck","year":"2009","journal-title":"J Affect Disord"},{"key":"R73-2-20210129","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1176\/appi.ajp.160.4.741","article-title":"Ziprasidone in Mania Study Group. Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial.","volume":"160","author":"Keck","year":"2003","journal-title":"Am J Psychiatry"},{"key":"R74-2-20210129","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/01.jcp.0000169068.34322.70","article-title":"Ziprasidone in acute bipolar mania: a 21-day randomized, double-blind, placebo-controlled replication trial.","volume":"25","author":"Potkin","year":"2005","journal-title":"J Clin Psychopharmacol"},{"key":"R75-2-20210129","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1177\/0269881108099418","article-title":"Ziprasidone in the treatment of acute mania: a 12-week, placebo-controlled, haloperidol-referenced study.","volume":"24","author":"Vieta","year":"2010","journal-title":"J Psychopharmacol"},{"key":"R76-2-20210129","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/BF00431272","article-title":"Dopamine and mania: behavioral and biochemical effects of the dopamine receptor blocker pimozide.","volume":"67","author":"Post","year":"1980","journal-title":"Psychopharmacology (Berl)"},{"key":"R77-2-20210129","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0165-0327(89)90064-5","article-title":"Sulpiride treatment of acute mania with a comparison of the effects on plasma hormone concentrations of lithium and sulpiride treatment.","volume":"16","author":"Christie","year":"1989","journal-title":"J Affect Disord"},{"key":"R78-2-20210129","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1176\/appi.ajp.159.7.1146","article-title":"Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety.","volume":"159","author":"Sachs","year":"2002","journal-title":"Am J Psychiatry"},{"key":"R79-2-20210129","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/archpsyc.59.1.62","article-title":"Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy.","volume":"59","author":"Tohen","year":"2002","journal-title":"Arch Gen Psychiatry"},{"key":"R80-2-20210129","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1192\/bjp.182.2.141","article-title":"Mood stabilisers plus risperidone or placebo in the treatment of acute mania. International, double-blind, randomised controlled trial.","volume":"182","author":"Yatham","year":"2003","journal-title":"Br J Psychiatry"},{"key":"R81-2-20210129","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1399-5618.2004.00115.x","article-title":"Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study.","volume":"6","author":"Sachs","year":"2004","journal-title":"Bipolar Disord"},{"key":"R82-2-20210129","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1176\/appi.ajp.162.7.1281","article-title":"Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial.","volume":"162","author":"Tohen","year":"2005","journal-title":"Am J Psychiatry"},{"key":"R83-2-20210129","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1176\/appi.ajp.163.2.247","article-title":"Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine.","volume":"163","author":"Tohen","year":"2006","journal-title":"Am J Psychiatry"},{"key":"R84-2-20210129","doi-asserted-by":"crossref","first-page":"626","DOI":"10.4088\/JCP.v67n0414","article-title":"; Aripiprazole Study Group. A randomized, double-blind, placebo-controlled 26-week trial of aripiprazole in recently manic patients with bipolar I disorder.","volume":"67","author":"Keck","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"R85-2-20210129","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.4088\/JCP.v68n1003","article-title":"; Aripiprazole Study Group. Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: a 100-week, double-blind study versus placebo.","volume":"68","author":"Keck","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"R86-2-20210129","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jad.2008.06.001","article-title":"Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126).","volume":"109","author":"Vieta","year":"2008","journal-title":"J Affect Disord"},{"key":"R87-2-20210129","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1176\/appi.ajp.2008.08020189","article-title":"Paulsson B; Trial 127 Investigators. Maintenance treatment for patients with bipolar I disorder: results from a North American study of quetiapine in combination with lithium or divalproex (trial 127).","volume":"166","author":"Suppes","year":"2009","journal-title":"Am J Psychiatry"},{"key":"R88-2-20210129","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.4088\/JCP.v67n0703","article-title":"A 7-week, randomized, double-blind trial of olanzapinefluoxetine combination versus lamotrigine in the treatment of bipolar I depression.","volume":"67","author":"Brown","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"R89-2-20210129","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1017\/S1461145708009735","article-title":"Olanzapinefluoxetine combination vs. lamotrigine in the 6-month treatment of bipolar I depression.","volume":"12","author":"Brown","year":"2009","journal-title":"Int J Neuropsychopharmacol"},{"key":"R90-2-20210129","doi-asserted-by":"crossref","first-page":"611","DOI":"10.4088\/JCP.v66n0511","article-title":"Analyses of treatment-emergent mania with olanzapinefluoxetine combination in the treatment of bipolar depression.","volume":"66","author":"Keck","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"R91-2-20210129","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0165-0327(02)00317-8","article-title":"Clonazepam and lorazepam in acute mania: a Bayesian meta-analysis.","volume":"78","author":"Curtin","year":"2004","journal-title":"J Affect Disord"},{"key":"R92-2-20210129","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/00004714-199010060-00004","article-title":"Double-blind comparison of the effects of clonazepam and lorazepam in acute mania.","volume":"10","author":"Bradwejn","year":"1990","journal-title":"J Clin Psychopharmacol"},{"key":"R93-2-20210129","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/(SICI)1099-1077(199707\/08)12:4<325::AID-HUP856>3.0.CO;2-H","article-title":"Clonazepam vs. lithium in mania: a controlled single blind randomised trial.","volume":"12","author":"Clark","year":"1997","journal-title":"Hum Psychopharmacol"},{"key":"R94-2-20210129","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3109\/00048679109077740","article-title":"Clonazepam in acute mania: a double blind trial.","volume":"25","author":"Edwards","year":"1991","journal-title":"Aust N Z J Psychiatry"},{"key":"R95-2-20210129","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1176\/ajp.146.1.77","article-title":"Clonazepam treatment of five lithium-refractory patients with bipolar disorder.","volume":"146","author":"Aronson","year":"1989","journal-title":"Am J Psychiatry"},{"key":"R96-2-20210129","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1001\/jama.1994.03520130039028","article-title":"Efficacy of divalproex vs. lithium and placebo in mania. Reply.","volume":"272","author":"Bowden","year":"1994","journal-title":"JAMA"},{"key":"R97-2-20210129","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/archpsyc.57.5.481","article-title":"A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group.","volume":"57","author":"Bowden","year":"2000","journal-title":"Arch Gen Psychiatry"},{"key":"R98-2-20210129","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1038\/sj.npp.1300190","article-title":"Maintenance efficacy of divalproex in the prevention of bipolar depression.","volume":"28","author":"Gyulai","year":"2003","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"R99-2-20210129","first-page":"CD004052","article-title":"Valproate for acute mood episodes in bipolar disorder.","author":"Macritchie","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"R100-2-20210129","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.4088\/JCP.v67n1003","article-title":"A randomized, placebo-controlled, multicenter study of divalproex sodium extended release in the treatment of acute mania.","volume":"67","author":"Bowden","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"R101-2-20210129","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s002130000380","article-title":"Carbamazepine and valproate monotherapy: feasibility, relative safety and efficacy, and therapeutic drug monitoring in manic disorder.","volume":"150","author":"Vasudev","year":"2000","journal-title":"Psychopharmacology (Berl)"},{"key":"R102-2-20210129","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.4088\/JCP.v69n1113","article-title":"Olanzapine versus divalproex versus placebo in the treatment of mild to moderate mania: a randomized, 12-week, double-blind study.","volume":"69","author":"Tohen","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"R103-2-20210129","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1176\/appi.ajp.159.6.1011","article-title":"Olanzapine versus divalproex in the treatment of acute mania.","volume":"159","author":"Tohen","year":"2002","journal-title":"Am J Psychiatry"},{"key":"R106-2-20210129","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/BF00428308","article-title":"Comparison of the antimanic efficacy of carbamazepine and chlorpromazine: a double-blind controlled study.","volume":"66","author":"Okuma","year":"1979","journal-title":"Psychopharmacology"},{"key":"R107-2-20210129","first-page":"89","article-title":"Carbamazepine versus lithium in mania: a double-blind study.","volume":"48","author":"Lerer","year":"1987","journal-title":"J Clin Psychiatry"},{"key":"R108-2-20210129","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1192\/bjp.153.2.198","article-title":"Carbamazepine vs. lithium in the treatment and prophylaxis of mania.","volume":"153","author":"Lusznat","year":"1988","journal-title":"Br J Psychiatry"},{"key":"R109-2-20210129","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/00004850-198907000-00005","article-title":"Carbamazepine compared to haloperidol in acute mania.","volume":"4","author":"Brown","year":"1989","journal-title":"Int Clin Psychopharmacol"},{"key":"R110-2-20210129","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1055\/s-2007-1014497","article-title":"Comparison of the antimanic efficacy of carbamazepine and lithium carbonate by double-blind controlled study.","volume":"23","author":"Okuma","year":"1990","journal-title":"Pharmacopsychiatry"},{"key":"R111-2-20210129","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1001\/archpsyc.1991.01810340047006","article-title":"Carbamazepine compared with lithium in the treatment of mania.","volume":"48","author":"Small","year":"1991","journal-title":"Arch Gen Psychiatry"},{"key":"R112-2-20210129","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0165-0327(85)90022-9","article-title":"The use of sodium valproate, carbamazepine and oxcarbazepine in patients with affective disorders.","volume":"8","author":"Emrich","year":"1985","journal-title":"J Affect Disord"},{"key":"R113-2-20210129","first-page":"83","article-title":"Studies with oxcarbazepine (trileptal) in acute mania.","volume":"5","author":"Emrich","year":"1990","journal-title":"Int Clin Psychopharmacol"},{"key":"R114-2-20210129","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1176\/ajp.2006.163.7.1179","article-title":"A double-blind, randomized, placebo-controlled trial of oxcarbazepine in the treatment of bipolar disorder in children and adolescents.","volume":"163","author":"Wagner","year":"2006","journal-title":"Am J Psychiatry"},{"key":"R115-2-20210129","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF00431111","article-title":"A preliminary double-blind study on the efficacy of carbamazepine in prophylaxis of manic-depressive illness.","volume":"73","author":"Okuma","year":"1981","journal-title":"Psychopharmacology (Berl)"},{"key":"R116-2-20210129","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1600-0447.1992.tb01453.x","article-title":"Carbamazepine versus lithium in the prophylaxis of bipolar affective disorder.","volume":"85","author":"Coxhead","year":"1992","journal-title":"Acta Psychiatr Scand"},{"key":"R117-2-20210129","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0165-0327(93)90057-Q","article-title":"The comparative efficacy of carbamazepine low and high serum level and lithium carbonate in the prophylaxis of affective disorders.","volume":"28","author":"Simhandl","year":"1993","journal-title":"J Affect Disord"},{"issue":"1","key":"R118-2-20210129","first-page":"CD005171","article-title":"Oxcarbazepine in the maintenance treatment of bipolar disorder.","author":"Vasudev","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"R119-2-20210129","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1017\/S1461145708008596","article-title":"A double-blind, randomized, placebo-controlled prophylaxis trial of oxcarbazepine as adjunctive treatment to lithium in the long-term treatment of bipolar I and II disorder.","volume":"11","author":"Vieta","year":"2008","journal-title":"Int J Neuropsychopharmacol"},{"key":"R120-2-20210129","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.pnpbp.2008.10.012","article-title":"Bipolar I and II disorder residual symptoms: oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial.","volume":"33","author":"Juruena","year":"2009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R121-2-20210129","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3109\/10401230009147081","article-title":"Lamotrigine compared with lithium in mania: a double-blind randomized controlled trial.","volume":"12","author":"Ichim","year":"2000","journal-title":"Ann Clin Psychiatry"},{"key":"R122-2-20210129","doi-asserted-by":"crossref","first-page":"841","DOI":"10.4088\/JCP.v61n1106","article-title":"A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 Study Group.","volume":"61","author":"Calabrese","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"R123-2-20210129","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.4088\/JCP.v64n0906","article-title":"; Lamictal 605 Study Group. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder.","volume":"64","author":"Calabrese","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"R124-2-20210129","doi-asserted-by":"crossref","first-page":"432","DOI":"10.4088\/JCP.v65n0321","article-title":"A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder.","volume":"65","author":"Goodwin","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"R125-2-20210129","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4088\/JCP.v60n0203","article-title":"A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group.","volume":"60","author":"Calabrese","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"R126-2-20210129","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/00004714-200106000-00015","article-title":"A pilot study of topiramate as monotherapy in the treatment of acute mania.","volume":"21","author":"Calabrese","year":"2001","journal-title":"J Clin Psychopharmacol"},{"issue":"1","key":"R127-2-20210129","first-page":"CD003384","article-title":"Topiramate for acute affective episodes in bipolar disorder.","author":"Vasudev","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"R128-2-20210129","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/00004714-200012000-00004","article-title":"A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders.","volume":"20","author":"Frye","year":"2000","journal-title":"J Clin Psychopharmacol"},{"key":"R129-2-20210129","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1034\/j.1399-5618.2000.20305.x","article-title":"Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy. Gabapentin Bipolar Disorder Study Group.","volume":"2","author":"Pande","year":"2000","journal-title":"Bipolar Disord"},{"key":"R130-2-20210129","doi-asserted-by":"crossref","first-page":"759","DOI":"10.4088\/JCP.v60n1107","article-title":"Tiagabine appears not to be efficacious in the treatment of acute mania.","volume":"60","author":"Grunze","year":"1999","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"R131-2-20210129","first-page":"CD004694","article-title":"Tiagabine in the treatment of acute affective episodes in bipolar disorder: efficacy and acceptability.","author":"Young","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"issue":"suppl 21","key":"R132-2-20210129","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1192\/S000712500029243X","article-title":"The challenge of predicting response to stabilising lithium treatment. The importance of patient selection.","volume":"163","author":"Grof","year":"1993","journal-title":"Br J Psychiatry"},{"key":"R133-2-20210129","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1034\/j.1399-5618.2003.00026.x","article-title":"Phenotypic spectra of bipolar disorder in responders to lithium versus lamotrigine.","volume":"5","author":"Passmore","year":"2003","journal-title":"Bipolar Disord"},{"key":"R135-2-20210129","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S0140-6736(03)12838-3","article-title":"Under-reporting of clinical trials is unethical.","volume":"361","author":"Antes","year":"2003","journal-title":"Lancet"}],"container-title":["Harvard Review of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00023727-201008000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T06:55:33Z","timestamp":1711781733000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00023727-201008000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":126,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.3109\/10673229.2010.507042","relation":{},"ISSN":["1067-3229"],"issn-type":[{"value":"1067-3229","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}